Tralokinumab Pre-Filled Pen Now Available in Canada
Tralokinumab (Adtralza, Leo) 300 mg/2 mL is now available as a pre-filled pen in Canada. A human, monoclonal antibody targeting the interleukin (IL)-13 cytokine, tralokinumab is currently indicated in patients 12 and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. […]